606 related articles for article (PubMed ID: 32858231)
21. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.
Sun Y; Jiang L; Shao X
Int Urol Nephrol; 2017 Dec; 49(12):2205-2216. PubMed ID: 28956241
[TBL] [Abstract][Full Text] [Related]
23. Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis.
Tian T; Wei B; Wang J
BMC Emerg Med; 2021 Jul; 21(1):81. PubMed ID: 34233608
[TBL] [Abstract][Full Text] [Related]
24. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
25. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia.
Milenkovic M; Hadzibegovic A; Kovac M; Jovanovic B; Stanisavljevic J; Djikic M; Sijan D; Ladjevic N; Palibrk I; Djukanovic M; Velickovic J; Ratkovic S; Brajkovic M; Popadic V; Klasnja S; Toskovic B; Zdravkovic D; Crnokrak B; Markovic O; Bjekic-Macut J; Aleksic A; Petricevic S; Memon L; Milojevic A; Zdravkovic M
Oxid Med Cell Longev; 2022; 2022():8997709. PubMed ID: 35237386
[TBL] [Abstract][Full Text] [Related]
26. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
[TBL] [Abstract][Full Text] [Related]
27. Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study.
Vanni G; Materazzo M; Dauri M; Farinaccio A; Buonomo C; Portarena I; Pellicciaro M; Legramante JM; Rizza S; Chiaramonte C; Bellia A; Grande M; Potenza S; Sbordone FP; Perrone MA; Grimaldi F; Chiocchi M; Buonomo OC
Anticancer Res; 2021 Jan; 41(1):307-316. PubMed ID: 33419825
[TBL] [Abstract][Full Text] [Related]
28. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
[TBL] [Abstract][Full Text] [Related]
30. [Construction of death early-warning model for patients with septic myocardial depression: a retrospective analysis of 129 patients].
Huang J; Zhou Y; Liu H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 May; 30(5):461-465. PubMed ID: 29764552
[TBL] [Abstract][Full Text] [Related]
31. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
33. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
[TBL] [Abstract][Full Text] [Related]
35. Changes of Serum Procalcitonin (PCT), C-Reactive Protein (CRP), Interleukin-17 (IL-17), Interleukin-6 (IL-6), High Mobility Group Protein-B1 (HMGB1) and D-Dimer in Patients with Severe Acute Pancreatitis Treated with Continuous Renal Replacement Therapy (CRRT) and Its Clinical Significance.
Gao N; Yan C; Zhang G
Med Sci Monit; 2018 Aug; 24():5881-5886. PubMed ID: 30136704
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
López-Ayala P; Alcaraz-Serna A; Valls Carbó A; Cuadrado Cenzual MÁ; Torrejón Martínez MJ; López Picado A; Martínez Valero C; Miranda JD; Díaz Del Arco C; Cozar López G; Suárez-Cadenas MDM; Jerez Fernández P; Angós B; Rodríguez Adrada E; Cardassay E; Del Toro E; Chaparro D; Montalvo Moraleda MT; Espejo Paeres C; García Briñón MÁ; Hernández Martín-Romo V; Ortega L; Fernández Pérez C; Martínez-Novillo M; González Armengol JJ; González Del Castillo J; Mueller CE; Martín-Sánchez FJ;
Emergencias; 2022 Apr; 34(2):119-127. PubMed ID: 35275462
[TBL] [Abstract][Full Text] [Related]
37. [Association of inflammatory indices with the severity of urinary sepsis: analysis of 70 cases].
Tan L; Yang C; Yang X; Wang Y; Cai G; Cao Z; Huang C; Xu D
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):93-99. PubMed ID: 30692073
[TBL] [Abstract][Full Text] [Related]
38. The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia.
Genç AB; Yaylacı S; Dheir H; Genç AC; İşsever K; Çekiç D; Kocayiğit H; Çokluk E; Karacan A; Şekeroğlu MR; Toptan Çakar H; Güçlü E
Turk J Med Sci; 2021 Apr; 51(2):448-453. PubMed ID: 33315349
[TBL] [Abstract][Full Text] [Related]
39. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
[TBL] [Abstract][Full Text] [Related]
40. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
